Avo vs C8 Health
Same clinician moment, opposite architectures. If your failure mode is guidance arriving too late in the workflow to change a decision, Avo sits inside the chart in both directions, reading patient data and pending orders back into Epic under a marketplace listing. If your failure mode is that the protocol already exists and nobody follows it, C8 Health is built for precisely that, unifying an institution's scattered standards into one searchable corpus and tracking adherence against it. The deepest split is the stewardship answer. Avo touches PHI and commits never to retain it; C8 never touches PHI at all, and therefore has no patient context to tailor an answer with. That is the whole trade in one line. Start with Avo for workflow depth and breadth, C8 for perioperative adherence.
- It is inside the chart in both directions, which is the deepest EHR position in this segment and the reason it grades A where C8 grades C. A live Epic Showroom listing and an athenahealth Marketplace listing, plus MEDITECH Expanse and Juno. It reads Care Everywhere data, radiology reports, labs, vitals, medications, notes, problem lists and diagnoses, and sends clinical notes and pended orders back into Epic. The Epic build is published at under 20 hours. C8 by design carries no patient context into an answer at all.
- Breadth of coverage rather than depth in one service line. Avo grades A on setting against C8's B: a library of digitised medical society guidelines spanning specialties and care settings, with dedicated propositions for rural and small hospitals, large and mid size hospitals and ambulatory care, and recommendations anchored to named published sources including society pathways, MCG recovery milestones and RAND consensus pathways. C8 is anchored in anesthesiology and perioperative services and its centre of gravity has not moved.
- It states where the data lives and what happens to it. The privacy notice commits that patient clinical data, explicitly including data collected through EHR integrations, is processed in real time only and is not stored, not saved and not sold, and it states plainly that servers are located in the United States. C8 publishes no data residency statement of any kind despite stated US and European operations and a Swiss origin, which is a live gap for a vendor claiming GDPR compliance.
- It removes the PHI question instead of answering it. C8 states it is SOC 2, GDPR and HIPAA compliant without requiring PHI for deployment, because the corpus is institutional knowledge rather than patient records. There is no clinical data exchange to build and a materially smaller compliance surface to negotiate. Avo reads deeply from the chart and writes back, which is a full business associate conversation, and its public privacy notice and terms mention neither HIPAA nor a business associate agreement anywhere. That gap is why it grades C here against C8's B.
- Accountability runs to a person rather than to a document. C8 Panda AI answers carry inline citations naming both the source document and its author, and in a local corpus that author is a named colleague at the same institution, so a clinician who doubts an answer can escalate to whoever wrote the protocol. Citation to a journal is the usual best case in this index; citation to a reachable colleague is stronger. C8 also grades higher on oversight, B against C.
- Where the right answer is genuinely local, a society guideline library is the wrong instrument. An antibiogram is by definition derived from one hospital's own resistance patterns and cannot come from a national content set. The same is true of any protocol shaped by local staffing, formulary or equipment. C8 is built for that case and adds the adherence tracking to prove it landed, with MetroHealth reporting ERAS protocol compliance moving from roughly 65 percent to over 88 percent.
Side-by-Side
| Axis | A Avo |
C C8 Health |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Both records were refreshed on 25 July 2026 and Avo's moved materially in that pass: six axes that had stood at Not Rated were graded from its privacy notice, terms of use and EHR integrations page, and its EHR grade was upgraded from B to A on the marketplace listings and bidirectional write back. A reader comparing against an earlier version of this grid will see different values. Evidence on both sides is thinner than the confident tone of either vendor's marketing. C8's clinical results are vendor reported and none carries a denominator, comparison period or control, and its one peer reviewed paper is a usage and adoption analysis of the pre commercial Geneva deployment rather than a clinical outcomes study. Avo's randomised trial reference and its claim of saving clinicians more than 50 percent of decision making time are vendor reported and were not independently verified here. Neither publishes enterprise pricing, which is the only tier a health system actually buys; Avo's sole published prices are two consumer specialty applications disclosed inside its terms of use. One commercial disclosure asymmetry is worth naming: Avo's privacy notice states that life sciences companies use its marketing solutions to fund and distribute clinical guidelines and to surface clinical trial and therapy information to clinicians, and that registration on its site includes registration with the DMD Healthcare Communications Network, under which clinician contact details are disclosed to network members by default, with that network's policy prevailing over Avo's own in any conflict. C8 discloses no equivalent arrangement. Finally, both operate cross institution content sharing, C8 through its Knowledge Network and Avo through its society and knowledge partner programmes, so the same unexamined question applies to each: when protocols from well resourced academic centres become the template smaller hospitals adopt, a guideline assuming staffing or equipment a hospital does not have is not a best practice there. C8's own pages also disagree on install base, stating more than 100 hospitals in one place and 150 plus in another.